From ‘Accelerate’ To ‘Confirm’: US FDA Launches Transparency Program On Cancer Drug Approvals

28 Oct 2021

Oncology Center of Excellence’s Project Confirm, formerly known as Project Accelerate, is intended to promote transparency of outcomes related to cancer drug accelerated approvals; initiative includes searchable databases on the status of oncology/hematology indications.

The US FDA Oncology Center of Excellence’s new transparency initiative on accelerated approvals is emphasizing the “confirm” part of the expedited pathway.

Project Confirm joins an ever-growing list of formal OCE initiatives, with this one aimed at promoting the transparency of outcomes...